- Report
- July 2026
- 191 Pages
Global
From €3218EUR$3,545USD£2,748GBP
€3575EUR$3,939USD£3,054GBP
- Report
- May 2026
- 189 Pages
Global
From €4084EUR$4,500USD£3,488GBP
- Report
- July 2026
- 369 Pages
Global
From €5310EUR$5,850USD£4,535GBP
- Report
- November 2025
- 160 Pages
Global
From €2868EUR$3,160USD£2,450GBP
€3585EUR$3,950USD£3,062GBP
- Report
- September 2025
- 200 Pages
Global
From €2260EUR$2,490USD£1,930GBP
- Report
- August 2025
- 190 Pages
Global
From €3218EUR$3,545USD£2,748GBP
€3575EUR$3,939USD£3,054GBP
- Report
- July 2026
- 192 Pages
Global
From €3218EUR$3,545USD£2,748GBP
€3575EUR$3,939USD£3,054GBP
- Report
- August 2025
- 188 Pages
Global
From €3218EUR$3,545USD£2,748GBP
€3575EUR$3,939USD£3,054GBP
- Report
- August 2025
- 180 Pages
Global
From €3218EUR$3,545USD£2,748GBP
€3575EUR$3,939USD£3,054GBP
- Report
- May 2026
- 180 Pages
Global
From €4084EUR$4,500USD£3,488GBP
- Report
- January 2026
- 181 Pages
Global
From €4084EUR$4,500USD£3,488GBP
- Report
- January 2026
- 185 Pages
Global
From €4084EUR$4,500USD£3,488GBP
- Report
- February 2026
- 250 Pages
Global
From €4075EUR$4,490USD£3,481GBP
- Report
- May 2026
- 250 Pages
Global
From €4075EUR$4,490USD£3,481GBP
- Report
- February 2026
- 250 Pages
Global
From €4075EUR$4,490USD£3,481GBP
- Report
- July 2026
- 349 Pages
Global
From €5310EUR$5,850USD£4,535GBP
- Report
- July 2026
- 193 Pages
Global
From €5310EUR$5,850USD£4,535GBP
- Report
- June 2026
- 180 Pages
Global
From €4311EUR$4,750USD£3,682GBP
- Report
- April 2026
- 158 Pages
Global
From €3585EUR$3,950USD£3,062GBP
- Newsletter
- July 2026
Global
€2718EUR$2,995USD£2,322GBP

Cell reprogramming is a biotechnology process that involves the conversion of a cell from one type to another. It is used to create induced pluripotent stem cells (iPSCs) from adult cells, which can then be used to study diseases, develop new treatments, and create personalized medicine. Cell reprogramming is also used to create cell models of diseases, which can be used to study the underlying mechanisms of the disease and develop new therapies. Additionally, cell reprogramming can be used to create cell-based therapies, such as gene therapy, which can be used to treat genetic diseases.
Cell reprogramming is a rapidly growing field, with many companies investing in the technology. Some of the companies in the market include Ginkgo Bioworks, Cellular Dynamics International, Fate Therapeutics, and Pluristem Therapeutics. Show Less Read more